QTPD Grant of $733K, BioTime (AMEX:BTX)
BTX has been awarded 3 grants totaling approximately $733,000 under the QTDP program.
- The grants awarded BTX were for the maximum amount allowed for 3 programs: Orthopedic product development, the ACTCellerateTM platform and the ReCyteTM program.
The QTDP program was part of the Patient Protection and Affordable Care Act. The QTDP was created by Congress to support investment in qualified biomedical projects that “show potential to develop new therapies, address unmet medical needs, and reduce the long-term growth of healthcare costs
